Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Meihao Medical Group Co., Ltd. ( (HK:1947) ) has shared an announcement.
Meihao Medical Group Co., Ltd. has convened its annual general meeting for 18 June 2026 in Wenzhou, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the year ended 31 December 2025. The meeting will also consider board changes, including the re-election of executive director Wang Xiaomin and independent non-executive director Tam Hon Shan Celia, and authorise the board to set directors’ pay and re-appoint McMillan Woods (Hong Kong) CPA Limited as auditor.
Shareholders will further vote on granting the board a general mandate to allot, issue and deal with additional shares up to 20% of the company’s issued share capital, excluding treasury shares, subject to certain standard exceptions such as rights issues and share option exercises. This share issuance authority, if approved, will run until the next annual general meeting or the statutory deadline, enhancing the company’s capital-raising flexibility and potentially supporting future financing, expansion or strategic transactions, which may influence ownership dilution and capital structure for existing investors.
More about Meihao Medical Group Co., Ltd.
Meihao Medical Group Co., Ltd. is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. Operating in the medical sector, it provides healthcare-related services and is focused on the mainland China market, with corporate activities and meetings held in Wenzhou, Zhejiang Province.
Average Trading Volume: 52,037
Technical Sentiment Signal: Buy
Current Market Cap: HK$249.1M
See more data about 1947 stock on TipRanks’ Stock Analysis page.